| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 07/02/2014 | CN102988366B 羟喜树碱的用途及鼻腔给药剂 HCPT and intranasal drug use |
| 07/02/2014 | CN102977360B 三苯基膦-聚乙二醇1000维生素e琥珀酸酯共轭化合物及其制备方法与应用 Triphenylphosphine - polyethylene glycol 1000 succinate vitamin e conjugated compound and its preparation method and application |
| 07/02/2014 | CN102977126B 一种双吲哚嗪取代衍生物及其制备方法和用途 A two-triazine-substituted indole derivatives and their preparation and use |
| 07/02/2014 | CN102924437B 3-哌嗪基-4-吲哚马来酰亚胺化合物及其制备和应用 3-piperazin-4 indolylmaleimide compounds and their preparation and application |
| 07/02/2014 | CN102924426B 胡椒乙胺缩5-氯水杨醛及其合成方法和应用 Pepper amine shrink 5- chlorosalicylaldehyde its synthesis method and application |
| 07/02/2014 | CN102920649B 载药纳米胶束及其制备方法和应用 Drug-loaded micelles and its preparation method and application |
| 07/02/2014 | CN102872066B 伊维菌素及其衍生物的用途 Use of ivermectin and its derivatives |
| 07/02/2014 | CN102781472B 放射线治疗剂 Radiation therapy agent |
| 07/02/2014 | CN102772805B 抑制mpg表达的产品在使细胞停留在g1期中的应用 Inhibit the expression product mpg in the cells stay in g1 period of application |
| 07/02/2014 | CN102772804B Maoa基因在肝癌治疗中的应用 Maoa gene used in the treatment of liver cancer |
| 07/02/2014 | CN102746360B 四种喜树碱-甾体缀合物的合成及其应用 Four kinds of camptothecin - steroid conjugates Synthesis and Application |
| 07/02/2014 | CN102731516B 一类具有抗肿瘤活性的喜树碱衍生物 A class of camptothecin derivatives have anti-tumor activity |
| 07/02/2014 | CN102702297B 胆酸-萘酰亚胺类化合物的制备方法 Acid - Preparation of compounds Naphthalimide |
| 07/02/2014 | CN102690264B 2-苯基-3-取代咪唑并[1,2-a]吡啶类衍生物及其制备方法 2-phenyl-3-substituted imidazo [1,2-a] pyridine derivatives and their preparation |
| 07/02/2014 | CN102652742B 来源于金针菇的倍半萜化合物的新用途 New uses from mushroom sesquiterpene compounds |
| 07/02/2014 | CN102617569B 一种具有抗肿瘤活性的β-咔啉类衍生物及其制备方法 Β- carboline derivatives and method for preparing anti-tumor activity |
| 07/02/2014 | CN102603858B 桦木醇的含氮杂环衍生物、制备方法及用途 Containing heterocyclic betulin derivatives, preparation method and use |
| 07/02/2014 | CN102603692B 一种抗肿瘤多药耐药抑制剂色满和色烯衍生物及其制备方法和应用 An anti-MDR inhibitor chroman and chromene derivatives and preparation method and application |
| 07/02/2014 | CN102526771B 包封uspio的隐形纳米脂质体注射液及其制备方法与应用 Stealth nano-encapsulated liposome injection and its preparation method and application uspio of |
| 07/02/2014 | CN102526018B 氨基甲酸紫草素酯在制备丙酮酸激酶抑制剂中的应用 Shikonin carbamate ester used in the preparation of pyruvate kinase inhibitor |
| 07/02/2014 | CN102516309B 一种能抑制肿瘤血管形成的钌配合物及其制备方法与应用 A ruthenium complexes can inhibit tumor angiogenesis and its preparation method and application |
| 07/02/2014 | CN102503995B 糖苷化4,4'-二甲基花椒毒素衍生物及其用途 Glycosylation 4,4'-dimethyl Xanthotoxin derivatives and their use |
| 07/02/2014 | CN102503930B 3,4,5,-三取代氨基噻吩类化合物及其制备和用途 3,4,5, - three amino-substituted thiophene compounds and their preparation and use |
| 07/02/2014 | CN102491978B 利用芦笋废弃资源制备天然色素、多糖、皂苷的方法 Preparation of asparagus waste resources utilization of natural pigments, polysaccharides, saponins methods |
| 07/02/2014 | CN102471338B 氮杂杂环化合物 Aza-heterocyclic compounds |
| 07/02/2014 | CN102459233B 二取代的酞嗪hedgehog途径拮抗剂 Disubstituted phthalazine hedgehog pathway antagonists |
| 07/02/2014 | CN102397398B 一种逆转肿瘤多药耐药的中药组合物及其制备方法和应用 One kind of reversal of multidrug resistance in traditional Chinese medicine composition and its preparation method and application |
| 07/02/2014 | CN102395372B 用于治疗造血组织肿瘤和白血病的苯并二氮*衍生物 Benzodiazepines for the treatment of hematopoietic tissue tumors and leukemia * Derivatives |
| 07/02/2014 | CN102391272B 1,4-二取代基-1,4-二氢苯并吡喃[4,3-c]吡唑类化合物 1,4-disubstituted-1,4-dihydro-benzo-pyran [4,3-c] pyrazole compounds |
| 07/02/2014 | CN102336825B 苦瓜蛋白、制备方法及在制备抗肿瘤药物中的应用 Momordicin, preparation method and its application in the preparation of antineoplastic |
| 07/02/2014 | CN102245607B 吗啉代嘌呤衍生物 Morpholino purine derivative |
| 07/02/2014 | CN102242154B 一种生产蝉拟青霉菌丝体的液体发酵方法及其培养产物的应用 A method of fermentation liquid Paecilomyces mycelium production cicadas and culture product applications |
| 07/02/2014 | CN102218027B 一种包载难溶性抗肿瘤药物的聚合物胶束冻干制剂 One kind of poorly soluble anticancer drugs entrapped polymer micelle lyophilized preparation |
| 07/02/2014 | CN102212008B 丹参素川芎嗪衍生物及其制备方法和应用 Danshensu TMP derivatives and preparation method and application |
| 07/02/2014 | CN102190728B 一种人源化抗cd20单克隆抗体 A humanized monoclonal antibody anti-cd20 |
| 07/02/2014 | CN102127147B 表皮生长因子受体模拟表位肽及其应用 Epidermal growth factor receptor analog epitope peptide and its application |
| 07/02/2014 | CN102108092B 23-羟基白桦酸衍生物及其制备方法和用途 23-hydroxyl betulinic acid derivatives and their preparation and use |
| 07/02/2014 | CN102093421B 一种含磷取代基的喹啉类化合物及其制备方法、以及含有该化合物的药物组合物及其应用 Quinoline compounds and a method for preparing a phosphorus-containing substituent, and the pharmaceutical compositions containing the compounds and uses thereof |
| 07/02/2014 | CN102048695B 一种制备用于体内递送药理活性物质的蛋白纳米粒的方法 In vivo delivery of a pharmacologically active substance a method for preparing protein nanoparticles |
| 07/02/2014 | CN102018698B 治疗雌激素受体相关疾病的化合物及其方法 Compound of the treatment of estrogen receptor-related diseases and a method |
| 07/02/2014 | CN102015686B 杂环化合物及其用途 Heterocyclic compounds and their use |
| 07/02/2014 | CN101977905B 4-吡啶酮化合物及其对于癌症的用途 4- pyridone compounds and their use for cancer |
| 07/02/2014 | CN101921587B 一种具有肿瘤细胞增殖抑制活性的荧光探针及其制备方法 An active preparation of fluorescent probes and tumor cell proliferation inhibition by |
| 07/02/2014 | CN101890030B 抗菌、抗病毒、抗氧化及抗色素沉积的组合物 Antibacterial, antiviral, antioxidant and anti-pigmentation composition |
| 07/02/2014 | CN101802013B 人源化抗cd79b抗体和免疫偶联物及使用方法 Humanized antibodies and immunoconjugates of anti cd79b and methods of use thereof |
| 07/02/2014 | CN101674846B ErbB3抗体及其用途 ErbB3 antibodies and their use |
| 07/01/2014 | US8765930 RNA interference mediating small RNA molecules |
| 07/01/2014 | US8765913 Human frizzled (FZD) receptor polypeptides and methods of use thereof for treating cancer and inhibiting growth of tumor cells |
| 07/01/2014 | US8765909 Metastin derivatives and use thereof |
| 07/01/2014 | US8765748 Indazolyl, benzimidazolyl, benzotriazolyl substituted indolinone derivatives as kinase inhibitors useful in the treatment of cancer |
| 07/01/2014 | US8765747 Fused 2-aminothiazole compounds |
| 07/01/2014 | US8765740 Cytotoxic benzodiazepine derivatives |
| 07/01/2014 | US8765734 Piperidin-4-yl azetidine derivatives as JAK1 inhibitors |
| 07/01/2014 | US8765729 Cancer therapy |
| 07/01/2014 | US8765713 Method for determination of sensitivity to anti-cancer agent |
| 07/01/2014 | US8765685 Methods for treating edema by administering a Soluble Hyaluronidase Glycoprotein (sHASEGP) |
| 07/01/2014 | US8765684 Solid materials of {[(2S,5R,8S,11S)-5-benzyl-11-(3-guanidino-propyl)-8-isopropyl-7-methyl-3,6,9,12,15-pentaoxo-1,4,7,10,13-pentaaza-cyclopentadec-2-yl]-acetic acid} and methods for obtaining them |
| 07/01/2014 | US8765683 T-140 peptide analogs having CXCR4 super-agonist activity for cancer therapy |
| 07/01/2014 | US8765677 Omega conotoxin peptides |
| 07/01/2014 | US8765666 Adenovirus dodecahedron particles for delivery of pharmaceutical agents |
| 07/01/2014 | US8765445 Equol-producing lactic acid bacteria-containing composition |
| 07/01/2014 | US8765432 Targeted drug phosphorylcholine polymer conjugates |
| 07/01/2014 | US8765139 Attenuated negative strand viruses with altered interferon antagonist activity for use as vaccines and pharmaceuticals |
| 06/26/2014 | WO2014100767A1 Isoquinolinone or quinazolinone phosphatidylinositol 3-kinase inhibitors |
| 06/26/2014 | WO2014100765A1 Substituted pyrimidine aminoalkyl-quinazolones as phosphatidylinositol 3-kinase inhibitors |
| 06/26/2014 | WO2014100762A1 Hydrophilic self-immolative linkers and conjugates thereof |
| 06/26/2014 | WO2014100734A1 Prmt5 inhibitors and uses thereof |
| 06/26/2014 | WO2014100700A1 Cytoprotective derivatives of avicin d and methods of making and using thereof |
| 06/26/2014 | WO2014100689A1 Anti-gdf15 antibodies |
| 06/26/2014 | WO2014100665A1 1,4-pyridone bicyclic heteroaryl compounds |
| 06/26/2014 | WO2014100662A1 Dot1 l inhibitors for use in the treatment of leukemia |
| 06/26/2014 | WO2014100646A1 1,4-pyridone compounds |
| 06/26/2014 | WO2014100615A1 Chimeric antigen receptor-expressing t cells as anti-cancer therapeutics |
| 06/26/2014 | WO2014100578A1 Peptides useful for modulating histone demethylase function |
| 06/26/2014 | WO2014100565A1 Methods and compositions relating to treatment of cancer |
| 06/26/2014 | WO2014100533A1 NOVEL SUBSTITUTED IMIDAZOLES AS CASEIN KINASE 1 δ/ε INHIBITORS |
| 06/26/2014 | WO2014100503A1 Drug delivery vehicles |
| 06/26/2014 | WO2014100486A1 Artemisinin compounds and synthesis and use thereof |
| 06/26/2014 | WO2014100438A1 Cycloalkenyl hydroxamic acid derivatives and their use as histone deacetylase inhibitors |
| 06/26/2014 | WO2014100431A1 Deuterated alk inhibitors |
| 06/26/2014 | WO2014100417A1 Compounds, compositions, and methods for the treatment of cancers |
| 06/26/2014 | WO2014100367A1 Synthesis of fr901464 and analogs with antitumor activity |
| 06/26/2014 | WO2014100314A1 Thiazole-substituted aminopyridines as spleen tyrosine kinase inhibitors |
| 06/26/2014 | WO2014100065A1 Substituted imidazopyridines as hdm2 inhibitors |
| 06/26/2014 | WO2014099880A1 Aryl-substituted fused bicyclic pyridazine compounds |
| 06/26/2014 | WO2014099503A1 Triazolone compounds and uses thereof |
| 06/26/2014 | WO2014098932A1 Treatment of mtor hyperactive related diseases and disorders |
| 06/26/2014 | WO2014098649A1 Compositions and methods using toll-like receptor 5 and toll-like receptor agonist |
| 06/26/2014 | WO2014098354A1 Pharmaceutical composition for treating muscle-invasive bladder cancer, containing s100a9 and egfr inhibitors and cisplatin as active ingredients |
| 06/26/2014 | WO2014098307A1 Anticancer pharmaceutical composition |
| 06/26/2014 | WO2014098210A1 Apoptosis-inducing agent |
| 06/26/2014 | WO2014098176A1 Amorphous form of quinoline derivative, and method for producing same |
| 06/26/2014 | WO2014098012A1 Method for activating helper t cell |
| 06/26/2014 | WO2014097875A1 Development of pluripotent stem cell employing novel dedifferentiation induction method |
| 06/26/2014 | WO2014097648A1 Gpc3-targeted therapeutic agent for administration to patients for whom gpc3-targeted therapeutic agent therapy is effective |
| 06/26/2014 | WO2014097125A1 Pharmaceutical combination comprising binimetinib |
| 06/26/2014 | WO2014096551A1 Linker-payload molecule conjugates |
| 06/26/2014 | WO2014096454A1 Soluble, dispersible or orodispersible tablets comprising cyclophosphamide |
| 06/26/2014 | WO2014096423A1 Therapeutically active pyrazolo-pyrimidine derivatives |
| 06/26/2014 | WO2014096399A1 Manipulation of hairy and split 3 (hes3) and its regulators/mediators as a new anti-cancer strategy |